Physician profile
Devin Keith Binder
NPI 1992804819
$10,302.85
in general payments reported to CMS, 2019-2025
15 companies · $784 in 2025
The $784 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,253 · 2020: $1,332 · 2021: $561 · 2022: $747 · 2023: $720 · 2024: $904 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,408.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Choice Spine, LLC | $4,781.23 | 2019-2021 | |
| Insightec,INC | $2,098.67 | 2020-2025 | Exablate |
| Boston Scientific Corporation | $925.02 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $653.37 | 2022-2025 | Infinity, Eterna, Lamitrode Tripole |
| Xtant Medical INC | $522.26 | 2021-2022 | |
| Baxter Healthcare | $337.40 | 2019-2025 | Floseal |
| Medtronic USA, INC. | $315.91 | 2019-2020 | |
| Abbvie INC. | $239.18 | 2024-2025 | |
| Nevro Corp. | $136.40 | 2024 | Senza |
| Medtronic, INC. | $113.20 | 2021-2024 | Activa PC, Strata |
| Integra Lifesciences Corporation | $74.51 | 2021-2022 | |
| Irras USA, INC. | $42.00 | 2020 | |
| Centinel Spine, LLC | $28.02 | 2024 | Prodisc C Vivo |
| Stryker Corporation | $21.75 | 2019 | |
| Lemaitre Vascular, INC. | $13.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Binder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.